Login  |  Register

Phase 2A Study of Setipiprant Tablets in Androgenetic ...

This study will evaluate the safety, tolerability and efficacy of the oral administration of setipiprant tablets 1000 mg twice daily (BID) relative to placebo in 18 ...

Alexa Traffic


Listing Links